Professional Services

The Drug Plan and Extended Benefits Branch (DPEBB) will remunerate pharmacies for witnessing the administration of approved Hepatitis C medications to eligible patients. The purpose of this program is to optimize patient medication adherence by reducing the risk of treatment interruption for approved Hepatitis C medications.

The Saskatchewan Medication Assessment Program or SMAP is a provincial program available to beneficiaries under the Drug Plan and Extended Benefits Branch (DPEBB) age 65 and older who are community-based, living in their own residence, taking five (5) or more chronic or taking an anticoagulant or taking a Beers List medication. 

These patients may receive an annual medication assessment and if eligible and require, follow-ups and compliance packaging. Patients living in an approved private service home or group home are eligible for an annual medication assessment.

Mandatory Documentation

* New Mandatory  SMAP Documentation

The Ministry of Health recently announced changes to the  Saskatchewan Medication Assessment Program (SMAP) documentation as noted in the  # 639 Pharmacy Information Bulletin - SMAP Documentation . These changes will become mandatory as of September 1, 2017. These new forms may be used effective immediately.  

You will be required to use the new forms (below) in order for your pharmacy to receive remuneration from the Drug Plan and Extended Benefits Branch (DPEBB) for conducting a medication assessment under SMAP. If you have your own forms, they must be approved by the DPEBB prior to use in order for the SMAP fees to be eligible for remuneration. All previously approved forms will need to be re-approved to ensure they meet the DPEBB’s current requirements of the program.

The Pharmacist Guide to SMAP (the “Guide”) was developed by PAS and the staff at the Medication Assessment Centre (MAC) to support pharmacists and pharmacy students. The Guide showcases a stepwise approach to performing a medicaiton assessment and demonstrates how the process can be applied to the new SMAP documenation forms (or any other medicaiton assessment documentation).

Please review the  Medication Assessment  Program Comparison Chart for eligibility.

The SMAP Mandatory Documentation forms below may be used until August 31, 2017. These forms have been developed by PAS and CPhA (adapted from CPhA's Pharmacheck Program) to fulfil the documentation requirements of the SMAP program. 

Please Note:  Documentation other than the forms produced by PAS, must be approved by the Drug Plan to prevent audit claw back.

Eligible Drug Plan Extended Benefits Branch (DPEBB) beneficiaries may receive an annual medication assessment and compliance packaging if they are:

• receiving homecare or mental health services, living in their own homes or
• any patients living in an approved Community Living Service Delivery Group Homes (CLSD)

Please note: Although specific documentation is not mandatory, pharmacists are encouraged to use SMAP documentation for consistency.

Please review the MA Program Comparison Chart for Eligibility.

Minor Ailment prescribing is a Level 1 Activity. Pharmacists providing minor ailment services to patients must follow the most recent Minor Ailment Guidelines and Documentation developed by medSask. Updates to Guidelines can happen at any time so check back often or subscribe to medSask News to receive email notifications.

Please note:

All Saskatchewan residents with a valid health card (including NIHB, DVA or other federal beneficiaries) are eligible to receive this billable service funded by the provincial Drug Plan.

All other Level 1 activities including: Interim Supplies, Unable to Access Supplies, Emergency Supply, Missing Information, Alter Dosage Form and Drug Reconciliation Activities Billing Policy are referenced in the Drug Plan's series of Prescriptive Authority for Pharmacists Pharmacy Information Bulletins:

In addition to a Special Edition PAS It On Bulleting #48, PAS also created a Guide and an FAQs made available below to PAS members:

Please note:

Details pertaining to Minor Ailment Prescribing are outdated in the above documents. For updated information, please refer to the Minor Ailments section on this Professional Services page.

PACT is a tobacco cessation program available to beneficiaries of the provincial Drug Plan. It incorporates Prochaska's "Stage of Change" theory and principles of Motivational Interviewing to support patients through their quit journey. Click here for more pharmacist and patient materials to support the delivery of the program. To see if you are listed as a PACT trained pharmacist, click here.

PAS in partnership with CPDPP and the SCA has updated PACT 1 & 2, the Oncology, and the Indigenous Tobacco training modules. The updated training modules are available on the CPDPP website. The updated training is free for all Saskatchewan pharmacists and pharmacy students. 

*Please note: certification is required for any PACT counseling that is Bronze Plus and up*

Mandatory Documentation

The PACT forms below have been developed by PAS to fulfill the documentation requirements of the PACT Policy and Procedure. All forms are mandatory if billing the Drug Plan.

Please note:

Documentation other than the forms produced by PAS must be approved by the Drug Plan to prevent audit clawback.

Billing Policy

The complete policy and procedure requirements of the program including beneficiaries, pseudoDINS, and program limitations can be found in the documents below.

All policy and procedure documents can also be found in the Bulletins page on the Drug Plan WEB page, accessible only in community pharmacies, and on the PACT webpages, accessible only by PAS Members. 

Pharmacies may charge a fee when a pharmacist provides seamless care services to a patient who is transferred from an institution to a community setting, in accordance with the Drug Plan's Seamless Care Policy

A pharmacy may charge a fee to the Drug Plan when a patient is enrolled in the TPP for eligible drugs, and Trial Prescription Program Policy is followed.

A pharmacy may charge a fee to the Drug Plan when refusing to dispense eligible prescriptions meeting specific criteria as per the Refusal To Dispense Fee Policy.

A managed care fee may be charged to the Drug Plan for patients receiving methadone for opioid addition as per the Methadone for the Management of Opioid Addictions Policy.